Retrospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology
Wounds: a compendium of clinical research and practice · 2026-07 · 38 (6) · 178-183
DOI: 10.25270/wnds/25123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wounds: a compendium of clinical research and practice, 2026-07. Verfasst von Anna Bradford und 5 weiteren Autor:innen. Beteiligte Einrichtung: W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; anna.bradford1@ucalgary.ca. Hauptthemen laut MEDLINE: Wound Healing, Diabetic Foot, Varicose Ulcer.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Chronic, nonhealing wounds have significant negative effects on both patients and the health system, including increased morbidity and mortality.
Objective
To retrospectively examine the effect of an advanced wound care treatment that delivers catalytic technology to the affected area through polymers that mimic the extracellular matrix. Materials and Methods. The proprietary catalytic treatment matrix (CTM) technology facilitates copper-dependent cellular signaling pathways within the wound healing process. Patients whose wounds were originally treated following standard wound care protocols and then subsequently transitioned to the catalytic technology (as determined by their physician), were recruited from a specialized outpatient wound care clinic in Calgary, Alberta, Canada. Data were collected from charts for 19 patients with a total of 26 chronic wounds (venous leg ulcers and diabetic foot ulcers). Following initiation of the catalytic technology, time to wound closure was tracked via percent area reduction, or for up to 16 weeks if wounds did not close.
Results
The average age of the wounds prior to application of the CTM technology was 39 weeks. After transitioning to CTM technology, 81% of wounds closed within 16 weeks. Notably, 77% of the wounds closed within the first 8 weeks (±2 days) of initiating use. Overall, the average time to closure was 43 days (median, 35 days).
Conclusion
CTM technology was shown to be an effective tool for improving time to closure of chronic wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; anna.bradford1@ucalgary.ca.
- W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
- Innovation and Business Intelligence, Alberta Health Services, Calgary, AB, Canada.
- Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; Glenrose Rehabilitation Hospital, Alberta Health Services, Edmonton, AB, Canada.
Zitieren
APA
Bradford, A., de Grood, J., Ambler, K., Noudeh, N. D., Wickson, P., & Ho, C. (2026). Retrospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology. Wounds: a compendium of clinical research and practice, 38(6), 178-183. https://doi.org/10.25270/wnds/25123
Vancouver
Bradford A, de Grood J, Ambler K, Noudeh ND, Wickson P, Ho C. Retrospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology. Wounds: a compendium of clinical research and practice. 2026;38(6):178-183. doi:10.25270/wnds/25123
BibTeX
@article{Bradford2026,
author = {Bradford, Anna and de Grood, Jill and Ambler, Kathryn and Noudeh, Negar Dehghan and Wickson, Patty and Ho, Chester},
title = {Retrospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology},
journal = {Wounds: a compendium of clinical research and practice},
year = {2026},
volume = {38},
number = {6},
pages = {178--183},
doi = {10.25270/wnds/25123}
}
EUVIMED